GE HealthCare (GEHC) Stock Tumbles Nearly 10% on Disappointing Q1 Results

Key Takeaways

• Q1 adjusted EPS came in at $0.99, falling short of the $1.05 analyst consensus
• Annual EPS outlook reduced to $4.80–$5.00 from previous range of $4.95–$5.15
• Quarterly revenue reached $5.13 billion, surpassing the $5.03 billion forecast
• Shares declined approximately 9% during premarket hours
• Strategic reorganization merges two major divisions into a $14.6 billion business unit

GE HealthCare delivered weaker-than-anticipated first-quarter results and lowered its annual profit forecast, triggering a significant decline in shares during Wednesday’s premarket session.

The medical technology company reported adjusted earnings of $0.99 per share, falling short of analyst expectations for $1.05. However, the top-line performance told a more positive story — quarterly sales reached $5.13 billion, reflecting a 7.4% increase from the prior year and exceeding the Street’s $5.03 billion projection.

Operating margin performance came in at 13.5%, roughly one percentage point below Wall Street’s forecasts.

Shares tumbled approximately 9.6% to around $61.93 in premarket activity Wednesday morning, extending what has already been a challenging year. The stock had declined 16% year-to-date in 2026 prior to this week’s report.

GE HealthCare Technologies Inc., GEHC

Chief Executive Peter Arduini identified escalating costs as the primary factor behind the revised outlook. The company faced higher expenses across multiple categories including memory chips, petroleum products, and shipping during the three-month period. Arduini indicated that management anticipates mitigating more than half of these inflationary headwinds through strategic pricing adjustments and expense management initiatives.

The company lowered its full-year adjusted earnings guidance to a range of $4.80–$5.00 per share, compared to its earlier projection of $4.95–$5.15. This falls below the analyst consensus of $5.06. Despite the earnings adjustment, GE HealthCare maintained its organic revenue growth target of 3% to 4%.

Order growth registered at 1.1% for the quarter, while comparable sales expanded 2.9%.

Major Organizational Restructuring

The medical equipment manufacturer revealed plans to consolidate its two primary divisions — imaging and advanced visualization solutions — into a unified segment named Advanced Imaging Solutions, which will oversee a combined revenue base totaling $14.6 billion.

Phil Rackliffe, previously responsible for advanced visualization solutions, will assume leadership of the newly integrated segment. Roland Rott, the former imaging division head, will depart from the organization.

Management characterized this strategic realignment as an effort to build a more integrated imaging platform while driving operational synergies.

Catherine Estrampes, a veteran employee with 35 years at the company, received appointment as Chief Commercial and Growth Officer to oversee a newly established global markets region encompassing all territories outside China.

Underperforming Its GE Siblings

GEHC has delivered the most disappointing returns among the three entities created from the legacy General Electric conglomerate. Following its January 2023 separation, shares have appreciated just 13%, underperforming the S&P 500 by more than 70 percentage points during this timeframe.

In stark contrast, GE Aerospace has rallied over 110% since the GE breakup completed in April 2024. GE Vernova has been the clear winner, skyrocketing more than 675% during the equivalent period.

GE Aerospace has capitalized on robust aircraft engine demand. GE Vernova has benefited from the boom in power infrastructure investment. GE HealthCare has confronted more challenging conditions — weak customer demand, tariff uncertainties, and ongoing inflationary pressures.

The medical technology firm does maintain a record order backlog approaching $22 billion as it entered 2026, which executives have highlighted as a cornerstone for future revenue expansion.

Prior to Wednesday’s earnings release, GEHC stock had gained only 1% over the trailing twelve-month period.

The post GE HealthCare (GEHC) Stock Tumbles Nearly 10% on Disappointing Q1 Results appeared first on Blockonomi.